MedTrace Logo

To Evaluate the Feasibility of Collecting Duodenal Fluid With SIMBA Capsules

NCT06708832 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-04-02

No results posted yet for this study

Summary

In this study, the feasibility to use SIMBA (Small Intestinal MicroBiome Aspiration) capsules to collect small intestinal microbiome and metabolome information will be evaluated in patients with liver cirrhosis. Furthermore, the comparability oral, fecal and small intestinal microbiome and metabolome composition based on similarities and differences in 16s sequencing data and NMR metabolomics data will be evaluated.

Conditions

Interventions

DEVICE

SIMBA ingestion

Ingestion of 2 SIMBA capsules at the same time and their excretion.

Sponsors & Collaborators

  • Nimble Science Ltd.

    collaborator INDUSTRY

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Vanessa Stadlbauer-Köllner, Assoc. Prof. · Medical University of Graz Department of Gastroenterology and Hepatology Auenbruggerplatz 15 8036 Graz

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2025-06-15
Completion
2025-06-15

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06708832 on ClinicalTrials.gov